MIRM
NASDAQ
US
Mirum Pharmaceuticals, Inc. - common stock
$94.17
▼ $-0.45
(-0.48%)
Vol 743K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$4.1B
ROE
-16.6%
Margin
-8.8%
D/E
105.93
Beta
0.50
52W
$37–$83
Wall Street Consensus
17 analysts · Apr 20266
Strong Buy
10
Buy
1
Hold
0
Sell
0
Strong Sell
94.1%
Buy Rating
Price Chart
Similar Stocks
PTGX
Protagonist Therapeutics Inc
P/E 118.9
$5.5B
RYTM
Rhythm Pharmaceuticals Inc
$7.1B
SRRK
Scholar Rock Holding Corp
$4.5B
COGT
Cogent Biosciences Inc
$5.4B
CGON
CG Oncology Inc
$3.3B
PTCT
PTC Therapeutics Inc
P/E 8.1
$6.1B
ERAS
Erasca Inc
$1.1B
CAI
Caris Life Sciences Inc
$7.6B
CELC
Celcuity Inc
$4.6B
TGTX
TG Therapeutics Inc
P/E 10.6
$4.7B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.04 | $-0.10 | $-0.14 |
| Sep 2025 | $-0.17 | $0.05 | +$0.22 |
| Jun 2025 | $-0.33 | $-0.12 | +$0.21 |
| Mar 2025 | $-0.34 | $-0.30 | +$0.04 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -24.7% | -24.8% | -24.8% | -24.8% | -16.6% | -16.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -4.6% | -13.7% | -13.7% | -13.7% | -8.8% | -8.8% |
| Gross Margin | 81.7% | 79.0% | 79.0% | 79.0% | 79.9% | 79.9% |
| D/E Ratio | 121.08 | 121.08 | 121.08 | 121.08 | 105.93 | 105.93 |
| Current Ratio | 3.13 | 3.13 | 3.13 | 3.13 | 3.31 | 3.31 |
Key Ratios
ROA (TTM)
-5.8%
P/S (TTM)
8.65
P/B
8.8
EPS (TTM)
$-0.87
CF/Share
$-4.10
Rev Growth 3Y
+160.1%
52W High
$82.58
52W Low
$36.88
$36.88
52-Week Range
$82.58
How does MIRM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MIRM valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
8.7
▼
33%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
8.8
▲
258%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MIRM profitability vs Biotechnology peers
ROE
-16.6%
▲
75%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-8.8%
▲
97%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
79.9%
▲
2%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-5.8%
▲
88%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
MIRM financial health vs Biotechnology peers
D/E ratio
105.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
3.3
▼
25%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.5
▼
48%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
MIRM fundamentals radar
MIRM
Peer median
Industry
MIRM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio